Press "Enter" to skip to content

New patent expiration for Janssen Pharms drug RISPERDAL CONSTA

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Janssen Pharms drug RISPERDAL CONSTA

Annual Drug Patent Expirations for RISPERDAL+CONSTA
Annual Drug Patent Expirations for RISPERDAL+CONSTA

Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

RISPERDAL CONSTA drug price trends.

Drug patent litigation for RISPERDAL CONSTA.

The generic ingredient in RISPERDAL CONSTA is risperidone. One supplier is listed for this compound. Additional details are available on the risperidone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Janssen Pharms drug RISPERDAL CONSTA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!